AIM IMMUNOTECH INC. (AIM) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$3.51M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$2.23M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$2.45M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.65M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$3.51M | (m) | $26.00K | (m) | (m) | -$4.59M* | (m) | $589.00K | (m) | (m) |
| 2026-03-31 | Reported | (m) | -$2.23M | (m) | $22.00K | (m) | (m) | -$2.72M | (m) | $482.00K | (m) | (m) |
| 2025-09-30 | Reported | (m) | -$2.45M | (m) | $26.00K | (m) | (m) | -$5.08M* | (m) | $607.00K | (m) | (m) |
| 2025-06-30 | Reported | (m) | -$2.65M | (m) | $25.00K | (m) | (m) | -$1.53M* | (m) | $1.17M | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$3.62M | (m) | $16.00K | (m) | (m) | -$2.36M | (m) | $1.08M | (m) | (m) |
| 2024-09-30 | Reported | (m) | -$4.49M | (m) | $35.00K | (m) | (m) | -$3.11M* | (m) | $1.44M | (m) | (m) |
| 2024-06-30 | Reported | (m) | -$3.69M | (m) | $50.00K | (m) | (m) | -$3.01M* | (m) | $1.15M | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$5.73M | (m) | $40.00K | (m) | (m) | -$4.82M | (m) | $1.95M | (m) | (m) |
| 2023-09-30 | Reported | (m) | -$8.16M | (m) | $46.00K | (m) | (m) | -$5.67M* | (m) | $2.73M | (m) | (m) |
| 2023-06-30 | Reported | (m) | -$5.46M | (m) | $42.00K | (m) | (m) | -$2.16M* | (m) | $2.95M | (m) | (m) |
| 2023-03-31 | Reported | (m) | -$4.29M | (m) | $49.00K | (m) | (m) | -$3.68M | (m) | $2.05M | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$6.52M | (m) | $21.00K | (m) | (m) | -$4.97M* | (m) | $1.37M | (m) | (m) |
| 2022-06-30 | Reported | (m) | -$4.70M | (m) | $30.00K | (m) | (m) | -$2.31M* | (m) | $2.48M | (m) | (m) |
| 2022-03-31 | Reported | (m) | -$3.15M | (m) | $33.00K | (m) | (m) | -$2.76M | (m) | $1.04M | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$3.93M | (m) | $33.00K | (m) | $8.00K* | -$3.46M* | (m) | $2.01M | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$3.72M | (m) | $23.00K | (m) | (m) | -$1.72M* | (m) | $1.32M | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$3.75M | (m) | $28.00K | (m) | (m) | -$3.04M | (m) | $1.42M | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$3.35M | (m) | $36.00K | (m) | $4.00K* | -$2.99M* | (m) | $1.10M | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$3.34M | (m) | $40.00K | (m) | $2.00K* | -$1.27M* | (m) | $1.46M | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$3.33M | (m) | $45.00K | (m) | $7.00K | -$3.25M | (m) | $898.00K | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$3.21M | (m) | $61.00K | (m) | $5.00K* | -$2.54M* | (m) | $1.19M | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$3.22M | (m) | $29.00K | (m) | $49.00K* | -$2.78M* | (m) | $1.10M | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$2.93M | (m) | (m) | (m) | $14.00K | -$1.46M | (m) | $928.00K | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$3.04M | (m) | $38.00K | (m) | (m) | -$2.98M* | (m) | $1.59M | (m) | (m) |
| 2018-06-30 | Reported | (m) | -$3.23M | (m) | $33.00K | (m) | (m) | -$2.70M* | (m) | $1.34M | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$2.57M | (m) | $56.00K | (m) | (m) | -$2.54M | (m) | $855.00K | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$2.65M | (m) | (m) | (m) | $17.00K* | -$1.88M* | (m) | $787.00K | (m) | (m) |
| 2017-06-30 | Reported | (m) | -$2.73M | (m) | (m) | (m) | $0.00* | -$2.31M* | (m) | $1.11M | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$3.24M | (m) | (m) | (m) | $3.00K | -$2.99M | (m) | $1.39M | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$3.23M | (m) | (m) | (m) | $0.00* | -$2.99M* | (m) | $1.34M | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$2.81M | (m) | (m) | (m) | (m) | -$1.25M* | (m) | $900.00K | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$3.68M | (m) | (m) | (m) | (m) | -$1.04M | (m) | $1.00M | (m) | (m) |
| 2015-09-30 | Reported | (m) | -$3.98M | (m) | (m) | (m) | -$14.00K* | -$3.50M* | (m) | $1.97M | (m) | (m) |
| 2015-06-30 | Reported | (m) | -$4.90M | (m) | (m) | (m) | $193.00K* | -$4.98M* | (m) | $2.44M | (m) | (m) |
| 2015-03-31 | Reported | (m) | -$4.92M | (m) | (m) | (m) | $47.00K | -$4.26M | (m) | $2.67M | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$4.33M | (m) | (m) | (m) | $120.00K* | -$3.73M* | (m) | $1.89M | (m) | (m) |
| 2014-06-30 | Reported | (m) | -$5.08M | (m) | (m) | (m) | $201.00K* | -$3.31M* | (m) | $2.33M | (m) | (m) |
| 2014-03-31 | Reported | (m) | -$5.11M | (m) | (m) | (m) | $65.00K | -$2.90M | (m) | $2.33M | (m) | (m) |
| 2013-09-30 | Reported | (m) | -$4.46M | (m) | (m) | (m) | $213.00K* | -$4.02M* | (m) | $2.17M | (m) | (m) |
| 2013-06-30 | Reported | (m) | -$4.73M | (m) | (m) | (m) | $290.00K* | -$3.78M* | (m) | $2.32M | (m) | (m) |
| 2013-03-31 | Reported | (m) | -$4.56M | (m) | (m) | (m) | $244.00K | -$5.85M | (m) | $2.34M | (m) | (m) |
| 2012-09-30 | Reported | (m) | -$4.96M | (m) | (m) | (m) | $1.61M* | -$2.70M* | (m) | $2.36M | (m) | (m) |
| 2012-06-30 | Reported | (m) | -$3.63M | (m) | (m) | (m) | $1.66M* | -$3.81M* | (m) | $1.74M | (m) | (m) |
| 2012-03-31 | Reported | (m) | -$3.75M | (m) | (m) | (m) | $1.55M | -$1.67M | (m) | $1.67M | (m) | (m) |
| 2011-09-30 | Reported | (m) | -$3.56M | (m) | (m) | (m) | $468.00K* | -$2.27M* | (m) | $1.75M | (m) | (m) |
| 2011-06-30 | Reported | (m) | -$3.25M | (m) | (m) | (m) | $345.00K* | -$2.98M* | (m) | $1.62M | (m) | (m) |
| 2011-03-31 | Reported | (m) | -$3.59M | (m) | (m) | (m) | $36.00K | -$1.82M | (m) | $1.64M | (m) | (m) |
| 2010-09-30 | Reported | (m) | -$3.69M | (m) | (m) | (m) | $152.00K* | -$2.68M* | (m) | $1.81M | (m) | (m) |
| 2010-06-30 | Reported | (m) | -$3.77M | (m) | (m) | (m) | (m) | (m) | (m) | $1.69M | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$11.66M | (m) | $88.00K | (m) | (m) | -$10.96M | (m) | $3.92M | (m) | (m) |
| 2024-12-31 | Reported | (m) | -$19.77M | (m) | $170.00K | (m) | $18.00K | -$14.89M | (m) | $6.20M | (m) | (m) |
| 2023-12-31 | Reported | (m) | -$31.92M | (m) | $202.00K | (m) | (m) | -$21.27M | (m) | $10.94M | (m) | (m) |
| 2022-12-31 | Reported | (m) | -$19.92M | (m) | $141.00K | (m) | $86.00K | -$16.11M | (m) | $6.99M | (m) | (m) |
| 2021-12-31 | Reported | (m) | -$18.84M | (m) | $135.00K | (m) | $41.00K | -$13.96M | (m) | $7.67M | (m) | (m) |
| 2020-12-31 | Reported | (m) | -$15.15M | (m) | $163.00K | (m) | $22.00K | -$10.37M | (m) | $5.72M | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$12.44M | (m) | $140.00K | (m) | $68.00K | -$9.07M | (m) | $4.65M | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$11.50M | (m) | $367.00K | (m) | $51.00K | -$10.64M | (m) | $4.78M | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$11.42M | (m) | (m) | (m) | $20.00K | -$7.94M | (m) | $4.10M | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$13.80M | (m) | (m) | (m) | $160.00K | -$7.38M | (m) | $5.11M | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$16.65M | (m) | (m) | (m) | $240.00K | -$16.05M | (m) | $8.04M | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$19.10M | (m) | (m) | (m) | $504.00K | -$13.96M | (m) | $8.99M | (m) | (m) |
| 2013-12-31 | Reported | (m) | -$17.17M | (m) | (m) | (m) | $898.00K | -$16.83M | (m) | $8.36M | (m) | (m) |
| 2012-12-31 | Reported | (m) | -$20.34M | (m) | (m) | (m) | $5.75M | -$13.14M | (m) | $9.51M | (m) | (m) |
| 2011-12-31 | Reported | (m) | -$14.29M | (m) | (m) | (m) | $1.80M | -$10.10M | (m) | $6.72M | (m) | (m) |
| 2010-12-31 | Reported | (m) | -$16.39M | (m) | (m) | (m) | $729.00K | -$11.89M | (m) | $7.61M | (m) | (m) |
| 2009-12-31 | Reported | (m) | -$13.26M | (m) | (m) | (m) | $332.00K | -$9.30M | (m) | $7.00M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |